Search

everythinglearnresearchcommunity

for

Search:↓

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Nanotechnology shows promise for better drug delivery and cancer treatment.

New treatments for skin and hair repair show promise, but further improvements are needed.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Some chemicals can permanently or temporarily remove color from skin and hair, which can be distressing and is not well-regulated in cosmetics.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

2Br-Crebanine and Stephanine reduce inflammation and pain effectively.

Gut bacteria can lower androgen levels in male mice.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

PRP treatment may help with alopecia areata, especially in newer cases.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Progesterone significantly reduces neuroblastoma tumor growth without harming healthy cells.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.